News

Sidekick Health Cracks the Code on Medication Adherence — Driving Better Outcomes and Lower Costs

NEW YORK, April 14, 2025 /PRNewswire/ -- Medication non-adherence is a significant and preventable challenge in healthcare, contributing to an…

8 months ago

Liviniti Named to Modern Healthcare’s 2025 Innovators List

Award honors top healthcare companies that are propelling the industry forward Natchitoches, Louisiana--(Newsfile Corp. - April 14, 2025) - Liviniti,…

8 months ago

Bruno Vision Care Receives FDA Approval for Deseyne® Contact Lens with FusionTechnology™

Lenses feature novel hydrogel material with patented controlled-release technology Only lenses available in the world that deliver hydration directly from…

8 months ago

Spectrum Vascular Welcomes New Executive Leadership

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Spectrum Vascular (“Spectrum” or the “Company”), a provider of vascular access and medication management products designed to…

8 months ago

Adia Nutrition Inc. Files for OTCQB Uplisting with OTC Markets, Emphasizing OTC-Handled 15c2-11 for Transparency and Investor Reach

Winter Park, Florida--(Newsfile Corp. - April 14, 2025) - Adia Nutrition Inc. (OTC Pink: ADIA), a leader in regenerative medicine…

8 months ago

Neural Therapeutics Strengthens IP Portfolio With a Patent Application

Treatment of Major DSM-5 Disorders, Including Addiction, Depression and Anxiety, With Sub-Hallucinogenic Mescaline DosesExtraction Technology Delivering Higher Yields and Greater…

8 months ago

Promino Nutritional Sciences Inc. Launches Second Preclinical Study Targeting Reduction of Muscle Loss in Breast and Prostate Cancer Patients Undergoing Chemotherapy

Research to explore Promino's patented amino acid blend in addressing treatment-related muscle wasting in two of the most prevalent cancers…

8 months ago

Free Oral Cancer Screenings in Honor of Oral, Head and Neck Cancer Awareness Month

26 USOSM Surgeon Partners to Participate Across Seven States IRVING, Texas, April 14, 2025 (GLOBE NEWSWIRE) -- In honor of…

8 months ago

VIVUS Announces Enrollment of First Patient in Phase 2 Clinical Trial Assessing Ethanol-Free Carmustine as a Component of High-Dose Chemotherapy Prior to Transplant in Patients with Hodgkin or Non-Hodgkin Lymphoma

— Innovative ethanol-free formulation intended to provide improved safety and advance care for patients undergoing high-dose conditioning therapy prior to…

8 months ago

NeuroOne® OneRF® Technology Success Story Featured on Fox News

Pediatric Patient Treated with OneRF® Ablation System Goes From Up to 10 Nightly Seizures to Zero EDEN PRAIRIE, Minn., April…

8 months ago